{"anticipatedPostingDate":"2009-11","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Platelet engraftment is defined as platelet counts \\> 50 x 10\\^9/Liter for 3 consecutive days.","groups":[{"description":"All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.","id":"OG000","title":"Evaluable Patients"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 Year Post Transplant","title":"Number of Participants (Patients) Who Attained Platelet Engraftment","type":"SECONDARY","unitOfMeasure":"Participants"}